GLA and Fabry disease: This CGI appears to enhance the enhancer’s long-range regulatory activity, which in turn helps to modulate the expressions of GLA. This information can aid in understanding the underlying causes of Fabry disease and potentially may lead to the development of new diagnostic and treatment methods.